ESMO Announces Christoph Zielinski as Editor-in-Chief of New Open-Access Journal
LUGANO, Switzerland, September 23, 2015 /PRNewswire/ --
ESMO, the leading professional organisation for medical oncology, announced that Professor Christoph Zielinski will be the Editor-in-Chief of ESMO Open, the new ESMO's peer-reviewed, open-access, online only journal. ESMO Open is dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research. The first articles will be published in January 2016.
"Being appointed Editor-in-Chief of ESMO Open is a lifetime dream come true," said Zielinski. "In my new role my goal is to publish significant science quickly in an open-access format."
Zielinski, 63, is Director of the Clinical Division of Oncology and Chairman of the Department of Medicine I and the Comprehensive Cancer Centre at the Medical University in Vienna, Austria. He has been President of the Central European Cooperative Oncology Group since 1999 and member of the ESMO Executive Board since 2014.
Zielinski's clinical speciality is medical oncology. His research focuses on clinical trials in breast, lung cancer, personalised medicine and immuno-oncology. He has published more than 600 papers.
"My priority as EiC will be to combine an even greater visibility for ESMO with critical reviews and comments on an open-access basis, on top of original papers," said Zielinski. "The editorial team will seek scientific manuscripts from across the oncology field, be it experimental or clinical. We want exceptional clinical challenges in reviews, original papers on cutting-edge technologies and scientific insights, ESMO news and views, and lively editorials - everything that makes a journal modern, exciting, and worth reading."
ESMO Open will operate a fast submission and review process with continuous publication online to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer-review process.
Zielinski concluded: "With the explosion of knowledge in oncology, an open-access journal was desperately needed. We will publish important papers quickly and be a crucial addition to ESMO's flagship Annals of Oncology."
Statement of Professor Christoph Zielinski: https://www.youtube.com/watch?v=QRxWxgMatA8
About ESMO
ESMO is the leading professional organisation for medical oncology. Comprising more than 11,000 oncology professionals from over 130 countries, ESMO is the society of reference for oncology education and information. Our educational and information resources support an integrated, multi-professional approach to cancer treatment. We seek to erase boundaries in cancer care as we pursue our mission across oncology, worldwide. http://www.esmo.org
About BMJ
BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. bmj.com
Contact:media@esmo.org, +41-79-935-60-73
Share this article